PE20080539A1 - Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c - Google Patents

Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c

Info

Publication number
PE20080539A1
PE20080539A1 PE2007001036A PE2007001036A PE20080539A1 PE 20080539 A1 PE20080539 A1 PE 20080539A1 PE 2007001036 A PE2007001036 A PE 2007001036A PE 2007001036 A PE2007001036 A PE 2007001036A PE 20080539 A1 PE20080539 A1 PE 20080539A1
Authority
PE
Peru
Prior art keywords
aryl
substituted
hepatitis
serine protease
pyridazinonyls
Prior art date
Application number
PE2007001036A
Other languages
English (en)
Spanish (es)
Inventor
Joel D Moore
Datong Tang
Yat Sun Or
Zhe Wang
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/832,893 external-priority patent/US7718612B2/en
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Publication of PE20080539A1 publication Critical patent/PE20080539A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
PE2007001036A 2006-08-04 2007-08-06 Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c PE20080539A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49984406A 2006-08-04 2006-08-04
US11/832,893 US7718612B2 (en) 2007-08-02 2007-08-02 Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

Publications (1)

Publication Number Publication Date
PE20080539A1 true PE20080539A1 (es) 2008-05-16

Family

ID=39033583

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001036A PE20080539A1 (es) 2006-08-04 2007-08-06 Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c

Country Status (4)

Country Link
CO (1) CO6020004A1 (fr)
EC (1) ECSP077649A (fr)
PE (1) PE20080539A1 (fr)
WO (1) WO2008019303A2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
TWI387603B (zh) 2005-07-20 2013-03-01 Merck Sharp & Dohme Ｈｃｖ ｎｓ３蛋白酶抑制劑
ES2356776T3 (es) 2005-10-11 2011-04-13 Intermune, Inc. Compuestos y métodos para inhibir la replicación del virus de la hepatitis.
RU2008152171A (ru) 2006-07-05 2010-08-10 Интермьюн, Инк. (Us) Новые ингибиторы вирусной репликации гепатита с
US8207341B2 (en) 2008-09-04 2012-06-26 Bristol-Myers Squibb Company Process or synthesizing substituted isoquinolines
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
TW201040181A (en) 2009-04-08 2010-11-16 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
WO2010135748A1 (fr) * 2009-05-22 2010-11-25 Sequoia Pharmaceuticals Inc. Inhibiteurs de la protéase ns3 du virus de l'hépatite c bimacrocyclique
US8232246B2 (en) 2009-06-30 2012-07-31 Abbott Laboratories Anti-viral compounds
TW201117812A (en) 2009-08-05 2011-06-01 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
US8933110B2 (en) 2010-01-25 2015-01-13 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
US8785487B2 (en) 2010-01-25 2014-07-22 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
EP2658859A4 (fr) 2010-12-30 2014-07-30 Enanta Pharm Inc Inhibiteurs macrocycliques de sérine protéase d'hépatite c
BR112013016480A2 (pt) 2010-12-30 2016-09-20 Abbvie Inc macrocíclo da fenantridina inibadores da protease da serina da hepatite c
US9353100B2 (en) 2011-02-10 2016-05-31 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
US8957203B2 (en) 2011-05-05 2015-02-17 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US8691757B2 (en) 2011-06-15 2014-04-08 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
RS55592B1 (sr) 2012-10-19 2017-06-30 Bristol Myers Squibb Co 9-metil supstituisani heksadekahidrociklopropa(e)pirolo(1,2-a)(1,4)diazaciklopentadecinil karbamat derivati kao nestrukturalni 3 (ns3) proteazni inhibitori za lečenje infekcijavirusom hepatitisa c
WO2014070964A1 (fr) 2012-11-02 2014-05-08 Bristol-Myers Squibb Company Inhibiteurs du virus de l'hépatite c
EP2914598B1 (fr) 2012-11-02 2017-10-18 Bristol-Myers Squibb Company Inhibiteurs du virus de l'hépatite c
US9643999B2 (en) 2012-11-02 2017-05-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2014070974A1 (fr) 2012-11-05 2014-05-08 Bristol-Myers Squibb Company Inhibiteurs du virus de l'hépatite c
US9310374B2 (en) * 2012-11-16 2016-04-12 Redwood Bioscience, Inc. Hydrazinyl-indole compounds and methods for producing a conjugate
US9580463B2 (en) 2013-03-07 2017-02-28 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
WO2015103490A1 (fr) 2014-01-03 2015-07-09 Abbvie, Inc. Formes galéniques antivirales solides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601709B2 (en) * 2003-02-07 2009-10-13 Enanta Pharmaceuticals, Inc. Macrocyclic hepatitis C serine protease inhibitors
KR100940619B1 (ko) * 2003-02-07 2010-02-05 이난타 파마슈티칼스, 인코포레이티드 마크로사이클릭 씨형 간염 세린 단백효소 억제제
US20040180815A1 (en) * 2003-03-07 2004-09-16 Suanne Nakajima Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors

Also Published As

Publication number Publication date
WO2008019303A3 (fr) 2008-10-30
ECSP077649A (es) 2008-03-26
CO6020004A1 (es) 2009-03-31
WO2008019303A2 (fr) 2008-02-14

Similar Documents

Publication Publication Date Title
PE20080539A1 (es) Piridazinonilos macrociclicos como inhibidores de serina proteasa de hepatitis c
PE20080992A1 (es) Quinoxalinil macrociclicos inhibidores de serina proteasa del virus de la hepatitis c
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
PE20080457A1 (es) Compuestos de oximilo macrociclico inhibidores de proteasas de hepatitis c
PE20050251A1 (es) Inhibidores de proteasas serinas, en especial proteasa ns3-ns4a del vhc
ATE526341T1 (de) Makrozyklische verbindungen als antivirale mittel
ATE528304T1 (de) Verbindungen und verfahren zur behandlung von dyslipidämie
EA201000201A1 (ru) Азотсодержащие бициклические химические вещества для лечения вирусных инфекций
CR9731A (es) Inhibidores de proteasa ns3 del vhc
TW200730478A (en) N-(6-membered aromatic ring)-amido anti-viral compounds
NO20080879L (no) HCV-NS3-proteaseinhibitorer
TW200720285A (en) Nucleoside compounds for treating viral infections
MX2009006880A (es) Derivados indolicos con anillo unido en las posiciones 4,5 para tratar o prevenir infecciones virales por virus de la hepatitis c e infecciones virales relacionadas.
EA200701850A1 (ru) Соединения трициклических нуклеозидов (варианты), фармацевтическая композиция на их основе и способ лечения или профилактики вирусных инфекций у млекопитающих
PE20070124A1 (es) Derivados de heteroaril para tratar virus
PE20081532A1 (es) Compuestos novedosos
CY1107200T1 (el) Ενωσεις αναστολης της ηπατιτιδας c
ES2322602T3 (es) Compuestos heterotetraciclicos condensados y su uso como inhibidor de polimerasa del vhc.
EA200500584A1 (ru) Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
WO2007070600A3 (fr) Composés antiviraux n-(noyau aromatique à 5 chaînons) amido
MA33209B1 (fr) Inhibiteurs de la replication du virus de l'hepatite c
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
AR062224A1 (es) Tetrazolilos macrociclicos como inhibidores de serina proteasa ns3 del virus de hepatitis c y composiciones farmaceuticas que los comprenden.
TW200602064A (en) Nucleoside derivatives for treating hepatitis C virus infection

Legal Events

Date Code Title Description
FC Refusal